See related GalvusMet information |
|
Manufacturer |
Novartis |
Distributor |
Hong Kong: Zuellig/Macau: Four Star |
Contents |
Per 50 mg/500 mg Vildagliptin 50 mg, metformin HCl 500 mg. Per 50 mg/850 mg Vildagliptin 50 mg, metformin HCl 850 mg. Per 50 mg/1,000 mg Vildagliptin 50 mg, metformin HCl 1,000 mg |
Indications |
Adjunct to diet & exercise to improve glycaemic control in patients w/ type 2 DM whose diabetes is not adequately controlled on metformin HCl or vildagliptin alone or who are already treated w/ the combination of vildagliptin & metformin HCl, as separate tab.
Click to view GalvusMet detailed prescribing infomation |
Dosage |
Max vildagliptin daily dose: 100 mg. Inadequately controlled on vildagliptin monotherapy Initially 50 mg/500 mg bd. Inadequately controlled on metformin HCl monotherapy Initially 50 mg/500 mg, 50 mg/850 mg or 50 mg/1,000 mg once or bd. Switching from combination therapy of vildagliptin plus metformin HCl, as separate tab Based from the dose of vildagliptin or metformin already being taken.
Click to view GalvusMet detailed prescribing infomation |
Overdosage |
View GalvusMet overdosage for action to be taken in the event of an overdose. |
Administration |
Should be taken with food (Take w/ or immediately after meals to reduce GI discomfort.). |
Contraindications |
Renal disease or dysfunction, CHF, diabetic ketoacidosis, intravascular administration of iodinated contrast materials.
Click to view GalvusMet detailed prescribing infomation |
Special Precautions |
Type 1 & 2 DM, hepatic impairment, hypoxemia, surgical procedures, hypoglycaemia, loss of blood glucose control. Monitor liver enzyme, renal function & serum vit B12. Pregnancy & lactation.
Click to view GalvusMet detailed prescribing infomation |
Adverse Drug Reactions |
Headache, tremor, dizziness. Urticaria.
View ADR Monitoring Form |
Drug Interactions |
Metformin HCl: Furosemide, nifedipine, cationic drugs, drugs that may produce hyperglycaemia, alcohol.
View more drug interactions with GalvusMet |
Description |
View GalvusMet description for details of the chemical structure and excipients (inactive components). |
Mechanism of Action |
View GalvusMet mechanism of action for pharmacodynamics and pharmacokinetics details. |

|